by Yannis Natsis | Nov 30, 2021 | #EU4Health, Universal Access and Affordable Medicines | Analysis & Opinion
The EU’s Pharmaceutical Strategy is a roadmap which will accompany policy developments for the years to come. It is important as it offers a rare and concise overview of actions and priorities which guide EU policy action. It is indeed a reference point as much as a...
by Raymond Gemen | Nov 25, 2021 | Health Inequalities
One in three women face gender-based violence in their lifetime, mostly by their intimate partner.This staggering statistic, however, dates from before COVID-19 and UN Women has reported on emerging evidence that since the outbreak of COVID-19, violence has...
by European Public Health Alliance | Nov 23, 2021 | Antimicrobial Resistance | Latest Developments
Antimicrobial resistance (AMR) represents a global health threat, which continues to worsen, despite the emerging realisation of the severity and magnitude of this problem. Furthermore, the coronavirus (COVID-19) pandemic has seen an increase in the use of...
by Sascha Marschang | Dec 10, 2020 | Europe and Health
EPHA members adopted a new Five-Year Strategy (2021-2025), “Artists and Scientists – New Partnerships for People’s Health” at the 2020 Annual General Assembly held on 3 December 2020.Responding to the need for both increased flexibility and multi-stakeholder...
by European Public Health Alliance | Apr 27, 2020 | Universal Access and Affordable Medicines | Latest Developments, Universal Access and Affordable Medicines | Publications
DOWNLOAD THE PAPER DOWNLOAD THE PR The increasing levels of medicine shortages across Europe pose severe threats to patient outcomes, patient safety and the patient care continuum. The European Public Health Alliance (EPHA) calls for an urgent resolution of the...
